Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.

Abstract

The efficacy of potassium iodide (KI) for Graves' disease (GD) has been reported, although few clinical reports have examined the long-term efficacy of treatment. The objective of this study was to investigate the efficacy and limitations of KI treatment for GD. This study enrolled patients newly diagnosed with mild GD, defined as free thyroxine (FT4) <5.0 ng/dL, between July 2014 and June 2016. KI was started at a dose of 50 mg/day, and if FT4 values did not decrease after initiation of treatment, doses were increased to 100 mg/day. Patients for whom thyroid hormone levels could not be controlled with KI at 100 mg/day were regarded as non-responders. Of the 122 patients (13 males, 109 females) included in this study, 71 (58.2%) responded to KI therapy. The remaining 51 patients (41.8%) were non-responders. The median duration required to judge non-responsiveness was 5.9 months. Multiple logistic regression analysis performed on parameters measured at the initial visit indicated FT4 (odds ratio (OR) 2.19, 95% confidence interval (CI) 1.28-3.75; p = 0.0007) and male sex (OR 3.58, 95%CI 1.04-12.3; p = 0.04) were significantly associated with KI responsiveness. Receiver operating characteristic (ROC) curve analysis of the relationship between FT4 and KI responsiveness indicated an FT4 cut-off of 2.76 ng/dL was optimal for differentiating between responders and non-responders. KI therapy was effective and safe for about 60% of patients with mild GD.

• Authors: Nami Suzuki, Jaeduk Yoshimura Noh, Chiho Sugisawa, Ayako Hoshiyama, Marino Hiruma, Akiko Kawaguchi, Mitsuha Morisaki, Hidemi Ohye, Miho Suzuki, Masako Matsumoto, Yo Kunii, Ai Yoshihara, Natsuko Watanabe, Kiminori Sugino, Kochi Ito
• Journal: Endocrine journal (Endocr J) Vol. 67 Issue 6 Pg. 631-638 (Jun 29 2020) ISSN: 1348-4540 [Electronic] Japan
• PMID: 32188795 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Triiodothyronine
• Potassium Iodide
• Thyroxine

Topics

• Adolescent
• Adult
• Aged
• Female
• Follow-Up Studies
• Graves Disease (blood, diagnosis, drug therapy, pathology)
• Humans
• Male
• Middle Aged
• Potassium Iodide (therapeutic use)
• Severity of Illness Index
• Thyroid Function Tests
• Thyroxine (blood)
• Treatment Outcome
• Triiodothyronine (blood)
• Young Adult